Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Senti Biosciences (SNTI) Asset Utilization Ratio (2021 - 2024)

Senti Biosciences (SNTI) has 3 years of Asset Utilization Ratio data on record, last reported at 0.02 in Q4 2023.

  • For Q4 2023, Asset Utilization Ratio changed N/A year-over-year to 0.02; the TTM value through Dec 2023 reached 0.02, changed N/A, while the annual FY2023 figure was 0.01, 57.35% down from the prior year.
  • Asset Utilization Ratio reached 0.02 in Q4 2023 per SNTI's latest filing, down from 0.02 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.02 in Q2 2023 and bottomed at 0.01 in Q4 2021.
  • Average Asset Utilization Ratio over 3 years is 0.02, with a median of 0.02 recorded in 2023.
  • The widest YoY moves for Asset Utilization Ratio: up 58.57% in 2023, down 23.69% in 2023.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then surged by 31.01% to 0.02 in 2022, then rose by 0.27% to 0.02 in 2023.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.02 in Q4 2023, 0.02 in Q3 2023, and 0.02 in Q2 2023.